These results, along with a previous report displaying that a small-molecule ACKR3 agonist CCX771 exhibits anxiolytic-like conduct in mice,2 support the notion of targeting ACKR3 as a novel strategy to modulate the opioid system, which could open up new therapeutic avenues for opioid-associated Conditions. In addition to the described https://manueldjczu.liberty-blog.com/33828427/how-conolidine-can-save-you-time-stress-and-money